BioSpace News Archive

Business

Seattle Genetics and Astellas Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

Submission Based on Pivotal Phase 2 Trial Results Recently Presented at Annual Meeting of American Society of Clinical Oncology

July 16, 2019
·
8 min read
Business

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments

Hugh Young Rienhoff, Jr., M.D., appointed as Chairman of the Board Charles A. Johnson, M.D., appointed to Board of Directors Alain Delcayre, Ph.D., appointed Senior Vice President of Research

July 16, 2019
·
4 min read
Business

Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019

Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

July 16, 2019
·
1 min read
BioCapital

NetNoggin® releases results from “Utilization of Technology in Alzheimer’s Disease” research study

NetNoggin® releases detailed results from a netnographic-qualitative research study concerning the utilization of technology in Alzheimer’s disease and MCI at the Alzheimer’s Association International Conference® (AAIC) 2019 Poster Session

July 16, 2019
·
2 min read
Deals

Varex Schedules Third Quarter Fiscal Year 2019 Earnings Release And Conference Call

Varex Imaging Corporation announced that it will report financial results for the third quarter of fiscal year 2019 following the close of regular trading on Tuesday, August 6, 2019.

July 16, 2019
·
1 min read
Deals

OncoSec Issues Letter to Shareholders

OncoSec Medical Incorporated, a company developing late-stage intratumoral cancer immunotherapies, published a Letter to Shareholders from President and Chief Executive Officer, Daniel J. O’Connor.

July 16, 2019
·
3 min read
Deals

BioMarin to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1 at 4:30pm ET

BioMarin Pharmaceutical Inc. announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 1, at 4:30 p.m. ET to discuss second quarter 2019 financial results and provide a general business update.

July 16, 2019
·
1 min read
Deals

Kindred Biosciences to Announce Second Quarter 2019 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Thursday, August 1, 2019

July 16, 2019
·
2 min read
Business

Astarte Medical Appoints Giulia Kennedy to Board of Directors

Company expands Board with scientific expertise as it advances development of NICUtrition® platform to improve outcomes for preterm infants

July 16, 2019
·
3 min read
Deals

Semler to Report Second Quarter and First Half 2019 Financial Results on July 26, 2019

Semler Scientific, Inc. announced that it will report financial results for the second quarter and first half ended June 30, 2019 before the open of U.S. financial markets on Friday, July 26, 2019.

July 16, 2019
·
1 min read